scholarly journals Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy

2021 ◽  
Vol 14 (3) ◽  
pp. 231
Author(s):  
James B. Doub ◽  
Vincent Y. Ng ◽  
Eleanor Wilson ◽  
Lorenzo Corsini ◽  
Benjamin K. Chan

Here, we present a case of a 79-year-old female with a recalcitrant Staphylococcal epidermidis prosthetic knee infection that was successfully treated with a single dose of adjuvant intra-articular bacteriophage therapy after debridement and implant retention surgery. The bacteriophage used in this case, PM448, is the first ɛ2 bacteriophage to be used in vivo. Currently the patient is without evidence of clinical recurrence and, interestingly, the patient had also suffered from debilitating aplastic anemia for over 2 years, which is recovering since receiving adjuvant bacteriophage therapy.

Author(s):  
María Ramírez Hidalgo ◽  
Alfredo Jover-Sáenz ◽  
Mercè García-González ◽  
Fernando Barcenilla-Gaite

2021 ◽  
Vol 8 ◽  
Author(s):  
Tristan Ferry ◽  
Cécile Batailler ◽  
Aubin Souche ◽  
Cara Cassino ◽  
Christian Chidiac ◽  
...  

Exebacase, a recombinantly produced lysin has recently (i) reported proof-of-concept data from a phase II study in S. aureus bacteremia and (ii) demonstrated antibiofilm activity in vitro against S. epidermidis. In patients with relapsing multidrug-resistant (MDR) S. epidermidis prosthetic knee infection (PKI), the only surgical option is prosthesis exchange. In elderly patients who have undergone several revisions, prosthesis explantation could be associated with definitive loss of function and mortality. In our BJI reference regional center, arthroscopic debridement and implant retention with local administration of exebacase (LysinDAIR) followed by suppressive tedizolid as salvage therapy is proposed for elderly patients with recurrent MDR S. epidermidis PKI with no therapeutic option or therapeutic dead end (for whom revision or transfemoral amputation is not feasible and no other oral option is available). Each use was decided in agreement with the French health authority and in accordance with the local ethics committee. A written consent was obtained for each patient. Exebacase (75 mg/mL; 30 mL) was administered directly into the joint during arthroscopy. Four patients (79–89 years old) were treated with the LysinDAIR procedure. All had several previous prosthetic knee revisions without prosthesis loosening. Three had relapsing PKI despite suppressive antibiotics following open DAIR. Two had clinical signs of septic arthritis; the two others had sinus tract. After the LysinDAIR procedure, no adverse events occurred during arthroscopy; all patients received daptomycin 8 mg/kg and linezolid 600 mg bid (4–6 weeks) as primary therapy, followed by tedizolid 200 mg/day as suppressive therapy. At 6 months, recurrence of the sinus tract occurred in the two patients with sinus tract at baseline. After >1 year follow up, the clinical outcome was favorable in the last two patients with total disappearance of clinical signs of septic arthritis even if microbiological persistence was detected in one of them. Exebacase has the potential to be used in patients with staphylococci PKI during arthroscopic DAIR as salvage therapy to improve the efficacy of suppressive antibiotics and to prevent major loss of function.


Author(s):  
Jorrit W. A. Schoenmakers ◽  
Marjolein Heuker ◽  
Marina López-Álvarez ◽  
Wouter B. Nagengast ◽  
Gooitzen M. van Dam ◽  
...  

Abstract Purpose Due to an increased human life expectancy, the need to replace arthritic or dysfunctional joints by prosthetics is higher than ever before. Prosthetic joints are unfortunately inherently susceptible to bacterial infection accompanied by biofilm formation. Accurate and rapid diagnosis is vital to increase therapeutic success. Yet, established diagnostic modalities cannot directly detect bacterial biofilms on prostheses. Therefore, the present study was aimed at investigating whether arthroscopic optical imaging can accurately detect bacterial biofilms on prosthetic joints. Methods Here, we applied a conjugate of the antibiotic vancomycin and the near-infrared fluorophore IRDye800CW, in short vanco-800CW, in combination with arthroscopic optical imaging to target and visualize biofilms on infected prostheses. Results We show in a human post-mortem prosthetic knee infection model that a staphylococcal biofilm is accurately detected in real time and distinguished from sterile sections in high resolution. In addition, we demonstrate that biofilms associated with the clinically most relevant bacterial species can be detected using vanco-800CW. Conclusion The presented image-guided arthroscopic approach provides direct visual diagnostic information and facilitates immediate appropriate treatment selection.


2014 ◽  
Vol 16 (1) ◽  
pp. 11-16 ◽  
Author(s):  
Andrzej Kaminski ◽  
Mustafa Citak ◽  
Thomas Schildhauer ◽  
Tobias Fehmer

2005 ◽  
Vol 20 (3) ◽  
pp. 401-405 ◽  
Author(s):  
John David ◽  
Rana M. Nasser ◽  
Jerry W. Goldberg ◽  
Kurt D. Reed ◽  
Mark D. Earll

2021 ◽  
Vol 11 (2) ◽  
pp. e20.00805
Author(s):  
Daniel A. Portney ◽  
Hayden P. Baker ◽  
Margaret M. Boyle ◽  
Victoria H. Barbosa ◽  
Hue H. Luu

2017 ◽  
Vol 18 (5) ◽  
pp. 619-624 ◽  
Author(s):  
David Joaquin Ortola ◽  
Domenico Fenga ◽  
Sandra Marcellino ◽  
Massimiliano Rosi ◽  
Francesco Centofanti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document